Literature DB >> 20107451

Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?

S Parikh1, P J Rosenthal.   

Abstract

Pregnant women are at particularly high risk for morbidity and mortality from malaria, and pregnancy can markedly affect drug pharmacokinetics, yet the pharmacokinetics of antimalarial drugs in pregnancy has been little studied. An important malaria-control measure in Africa is intermittent preventive therapy (IPT) with sulfadoxine-pyrimethamine (SP) during pregnancy. We discuss IPT with SP in light of several concerns and highlight recent findings from a pharmacokinetic study of SP in this population.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20107451     DOI： 10.1038/clpt.2009.284

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  8 in total

1.  Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

Authors:  Nana O Wilson; Fatou K Ceesay; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Patricia Rodney; Yassa Ndjakani; Winston A Anderson; Naomi W Lucchi; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 2.  Pharmacokinetics of antimalarials in pregnancy: a systematic review.

Authors:  Kyle J Wilby; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

3.  Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola.

Authors:  Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Virgílio E do Rosário; Cláudio Tadeu Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2011-08-24       Impact factor: 2.979

Review 4.  Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research.

Authors:  Christopher Pell; Lianne Straus; Erin V W Andrew; Arantza Meñaca; Robert Pool
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

5.  The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana.

Authors:  Christopher Pell; Arantza Meñaca; Samuel Chatio; Abraham Hodgson; Harry Tagbor; Robert Pool
Journal:  Malar J       Date:  2014-11-18       Impact factor: 2.979

6.  Burden of Placental Malaria among Pregnant Women Who Use or Do Not Use Intermittent Preventive Treatment at Mulago Hospital, Kampala.

Authors:  Charles Okot Odongo; Michael Odida; Henry Wabinga; Celestino Obua; Josaphat Byamugisha
Journal:  Malar Res Treat       Date:  2016-12-13

Review 7.  Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network.

Authors:  Liwang Cui; Sungano Mharakurwa; Daouda Ndiaye; Pradipsinh K Rathod; Philip J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2015-08-10       Impact factor: 2.345

8.  Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.

Authors:  Hamtandi Magloire Natama; Rouamba Toussaint; Djamina Line Cerine Bazié; Sékou Samadoulougou; Maminata Coulibaly-Traoré; Halidou Tinto; Fati Kirakoya-Samadoulougou
Journal:  Malar J       Date:  2020-11-10       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.